Nanocarriers and macrophage interaction: from a potential hurdle to an alternative therapeutic strategy

• Naths Grazia Sukubo,
• Paolo Bigini and
• Annalisa Morelli

Beilstein J. Nanotechnol. 2025, 16, 97–118, doi:10.3762/bjnano.16.10

• demonstrated by Ji and colleagues in a mouse model of carbon tetrachloride (CCl4)-induced fibrosis, where they inhibited the proliferation of fibroblasts [46]. An alternative to depletion is the inhibition of KCs through chloroquine, an antimalaria agent that inhibits macrophage-specific endocytosis, or

• by suppressing anti-inflammatory pathways, while miR-146a enhances endotoxin tolerance by modulating TLR signaling through Notch1 inhibition [68][69]. miR-221-3p drives M2 macrophages towards the M1 phenotype by inhibiting the JAK3/STAT3 signaling pathway. Conversely, miR-1246 promotes M2

Characterization of ZnO nanoparticles synthesized using probiotic Lactiplantibacillus plantarum GP258

• Prashantkumar Siddappa Chakra,
• Aishwarya Banakar,
• Shriram Narayan Puranik,
• Vishwas Kaveeshwar,
• C. R. Ravikumar and
• Devaraja Gayathri

Beilstein J. Nanotechnol. 2025, 16, 78–89, doi:10.3762/bjnano.16.8

• potential of −60 mV. Furthermore, the synthesized nanoparticles displayed significant antibacterial activity against selected human pathogens, with the biggest inhibition zone observed against Staphylococcus aureus (22 ± 0.57 mm) and the smallest inhibition zone observed against Salmonella enterica serovar

• -positive and Gram-negative pathogens. Of the five pathogens examined, three exhibited susceptibility to the ZnO NPs, while the remaining two showed reduced zones of inhibition, indicative of resistance. Noteworthy, susceptibility of Staphylococcus aureus, evidenced by the largest zone of inhibition

• . aureus were observed, with a zone of inhibition measuring 22 ± 1 mm. In contrast, Salmonella enterica serovar typhi showed lower susceptibility, with an inhibition zone of 3 ± 1 mm, though antibacterial activity was still evident. Suba et al. [22] also reported antibacterial activity of ZnO NPs

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

• Hugo Felix Perini,
• Beatriz Sodré Matos,
• Carlo José Freire de Oliveira and
• Marcos Vinicius da Silva

Beilstein J. Nanotechnol. 2024, 15, 1619–1626, doi:10.3762/bjnano.15.127

• nanoparticles (AuNPs) with polyoxometalate and the peptides POMD and LPFFD (AuNPs@POMD-pep) have shown inhibition of Aβ1 aggregation and Aβ-induced cytotoxicity. However, the inherent toxicity of this formulation, challenges in particle digestion, and the potential for triggering immune reactions remain

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• non-targeted PLHNPs. A pharmacodynamic study of targeted PLHNPs in DMBA-induced BC-bearing female BALB/c mice showed that the targeted PLHNPs yielded significantly enhanced and synergistic therapeutic efficacy and showed much better tumor inhibition and improved survival rate than the non-targeted

• controlled drug release characteristics for up to 48 h. In vivo therapeutic efficacy was determined in MCF-7 tumor-bearing BALB/c female mice. The developed PLHNPs revealed much better tumor inhibition potential than the native compound. Altogether, developing psoralen-encapsulated PLHNPs significantly

• improved antitumor efficacy against cervical cancer [139]. The formulation showed better stability and sustained release properties. Antitumor activity in U14 tumor-bearing female CD-1 mice revealed that the UA-PLHNPs exhibited much higher tumor growth inhibition. Further, UA-PLHNPs represented better

Effect of radiation-induced vacancy saturation on the first-order phase transformation in nanoparticles: insights from a model

• Aram Shirinyan and
• Yuriy Bilogorodskyy

Beilstein J. Nanotechnol. 2024, 15, 1453–1472, doi:10.3762/bjnano.15.117

• II in Figure 2. This correspondence highlights the significant impact of nucleation on the phase transition dynamics. Specifically, the presence of nucleation fundamentally alters the situation, leading to the possibility of phase transition inhibition due to the existence of a very high energy

Hymenoptera and biomimetic surfaces: insights and innovations

• Vinicius Marques Lopez,
• Carlo Polidori and
• Rhainer Guillermo Ferreira

Beilstein J. Nanotechnol. 2024, 15, 1333–1352, doi:10.3762/bjnano.15.107

• effective ultrasound equipment, thus improving patient outcomes in both diagnostics and treatment. Furthermore, studying the use of acoustic signals in hymenopterans may offer valuable inspiration for future research, as these context-dependent signals can modulate the production or inhibition of chemical

Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles

• André F. Lima,
• Giselle Z. Justo and
• Alioscka A. Sousa

Beilstein J. Nanotechnol. 2024, 15, 1208–1226, doi:10.3762/bjnano.15.98

• microenvironment, thus enhancing treatment efficacy. The study revealed that 64Cu-Cu@CuOx-ECL1i exhibited suitable biodistribution and biocompatibility. Moreover, 64Cu-Cu@CuOx-ECL1i-Gem was able to induce tumor inhibition and to prolong survival in a syngeneic xenograft mouse model of PDAC. 5.7 Antibody-based

Introducing third-generation periodic table descriptors for nano-qRASTR modeling of zebrafish toxicity of metal oxide nanoparticles

• Supratik Kar and
• Siyun Yang

Beilstein J. Nanotechnol. 2024, 15, 1142–1152, doi:10.3762/bjnano.15.93

• inhibition of the zebrafish hatching enzyme ZHE1 with the nano-qRASTR approach to improve the model quality, predictability, and reliability significantly. Materials and Methods Dataset The percentage decrease in enzymatic activity expressed in the form of enzyme inhibition to zebrafish in % (%EIzebrafish

• approach for the inhibition of ZHE1 hatching enzyme activity: The first descriptor represents the total metal electronegativity in a specific metal oxide and shows a negative correlation to the inhibition of the ZHE 1 hatching enzyme. In this case, an increase in electronegativity will result in a

• ), suggesting that nanomaterials composed of atoms with larger radii are associated with a decrease in %EIzebrafish. A larger atomic radius might indicate weaker bonding and less effective interaction with the enzyme or its substrate, leading to less enzyme inhibition. This could be due to the diffuse nature of

Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis

• Damai Ria Setyawati,
• Fransiska Christydira Sekaringtyas,
• Riyona Desvy Pratiwi,
• A’liyatur Rosyidah,
• Rohimmahtunnissa Azhar,
• Nunik Gustini,
• Gita Syahputra,
• Idah Rosidah,
• Etik Mardliyati,
• Tarwadi and
• Sjaikhurrizal El Muttaqien

Beilstein J. Nanotechnol. 2024, 15, 1105–1116, doi:10.3762/bjnano.15.89

• the activation of HSCs is the most important strategy in liver fibrosis therapy. It includes both inhibition of HSC proliferation and of pro-fibrogenic cytokine and growth factor secretion. In the last few years, the research on interferon γ (IFNγ), the angiotensin II-receptor antagonist Losartan

• overexpressed in activated HSCs and strongly related to the transformation of HSCs into matrix-producing myofibroblasts during liver fibrinogenesis [68][69]. The HSC-mediated antifibrotic drugs work through several mechanisms, including inhibition of fibrogenesis (ECM synthesis), inhibition of HSC proliferation

• , inhibition of profibrogenic cytokine and growth factors secretion, and induction of ECM degradation [70]. A summary of liver-targeted delivery systems is shown in Table 1. Passive and active delivery strategies were combined by Luo and co-workers, who prepared silibinin–human serum albumin nanocrystals [71

Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications

• Shakhzodjon Uzokboev,
• Khojimukhammad Akhmadbekov,
• Ra’no Nuritdinova,
• Salah M. Tawfik and
• Yong-Ill Lee

Beilstein J. Nanotechnol. 2024, 15, 1077–1104, doi:10.3762/bjnano.15.88

• the initial 120 h. Furthermore, in vitro tests showed the effective inhibition of MCF-7 human breast cells without any damage to human dermal fibroblasts (HDFs). The created new alginate-based nanoplatform can be used in targeted and prolonged drug delivery of capsaicin in cancer prevention and

Interface properties of nanostructured carbon-coated biological implants: an overview

• Mattia Bartoli,
• Francesca Cardano,
• Erik Piatti,
• Stefania Lettieri,
• Andrea Fin and
• Alberto Tagliaferro

Beilstein J. Nanotechnol. 2024, 15, 1041–1053, doi:10.3762/bjnano.15.85

• the FimH protein complex involved in bladder infection. CNTs also prevent the formation of biofilm as reported by Sivaraj et al. [126], who obtained zones of inhibition of up to 12 mm. Morco et al. [127] suggested that the biofilm inhibition by CNTs is mainly due to the increase of surface

Entry of nanoparticles into cells and tissues: status and challenges

• Kirsten Sandvig,
• Tore Geir Iversen and
• Tore Skotland

Beilstein J. Nanotechnol. 2024, 15, 1017–1029, doi:10.3762/bjnano.15.83

• as a control to see that the treatment reduces the uptake of this ligand. Chlorpromazine has been reported to lead to relocalization of clathrin and the adaptor AP2 from the plasma membrane and to endosomes [46]. Notably, this is associated with an inhibition of the recycling of receptors for α2

Electrospun polysuccinimide scaffolds containing different salts as potential wound dressing material

• Veronika Pálos,
• Krisztina S. Nagy,
• Rita Pázmány,
• Krisztina Juriga-Tóth,
• Bálint Budavári,
• Judit Domokos,
• Dóra Szabó,
• Ákos Zsembery and
• Angela Jedlovszky-Hajdu

Beilstein J. Nanotechnol. 2024, 15, 781–796, doi:10.3762/bjnano.15.65

• 8 h; however, only 50% of the zinc acetate was dissolved. In addition, antibacterial activity tests were performed with four different bacterial strains relevant to skin surface injuries, leading to the appearance of inhibition zones around the scaffold discs in most cases. We also investigated the

• the discs were incubated at 37 °C for 24 h, and then inhibition/diffuse zones were observed. The diameter of the inhibition zones is the area where bacteria do not appear at all. The diffuse zones defined in our paper are areas where the salt could diffuse out from the scaffold and start some clean-up

• zone in the agar (not a totally clean area from bacteria). These zones were measured by the ImageJ software, and with Equation 6, the specific antibacterial area was calculated [22]. The dzone means the diameter of the inhibition or diffuse zone and dscaffold means the diameter of the scaffolds after

Laser synthesis of nanoparticles in organic solvents – products, reactions, and perspectives

• Theo Fromme,
• Sven Reichenberger,
• Katharine M. Tibbetts and
• Stephan Barcikowski

Beilstein J. Nanotechnol. 2024, 15, 638–663, doi:10.3762/bjnano.15.54

• nanocomposites based on sp-hybridized carbon chains [64]. Liang et al. specified the conditions for inhibition of phase crystallization and, hence, the formation of metallic glass nanoparticles in organic solvents, which was attributed to the carbon doping of the amorphous phase as well as carbon shell formation

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

• Hsuan-Ang Tsai,
• Tsai-Miao Shih,
• Theodore Tsai,
• Jhe-Wei Hu,
• Yi-An Lai,
• Jui-Fu Hsiao and
• Guochuan Emil Tsai

Beilstein J. Nanotechnol. 2024, 15, 465–474, doi:10.3762/bjnano.15.42

• absorber [20]. In addition, silver (Ag) nanoparticles were synthesized from cotton fabrics and exhibited strong inhibition activity against some bacteria [21]. Recently, pure active pharmaceutical ingredient (API) composed of nanocrystals was investigated, as opposed to drug nanocarrier platforms [22

Classification and application of metal-based nanoantioxidants in medicine and healthcare

• Nguyen Nhat Nam,
• Nguyen Khoi Song Tran,
• Tan Tai Nguyen,
• Nguyen Ngoc Trai,
• Nguyen Phuong Thuy,
• Hoang Dang Khoa Do,
• Nhu Hoa Thi Tran and
• Kieu The Loan Trinh

Beilstein J. Nanotechnol. 2024, 15, 396–415, doi:10.3762/bjnano.15.36

• % DPPH inhibition and exhibit in vivo hepatoprotective properties in laboratory mice [12]. The combination of copper and cerium in nanoparticle structures enhances antioxidant activity through a synergistic effect. CuCe nanoparticles have been demonstrated for therapeutic effects in ischemic vascular

• ]. Antioxidants contribute to cancer inhibition and cancer treatment by several mechanisms. First, nanoantioxidants reduce cancer initiation by protecting DNA molecules from oxidative stress and stimulating DNA repair. For example, platinum nanoparticles inhibited the growth of epithelial lung cancer cells by

• between cerium(IV) and cerium(III). SOD activity immobilized through cross-linking on a Zr framework (SOD-ZrMOF) demonstrates effective scavenging of ROS and inhibition of oxidative stress. A prolonged investigation using an animal model of acute myocardial infarction revealed that SOD-ZrMOF has the

Controllable physicochemical properties of WO_x thin films grown under glancing angle

• Rupam Mandal,
• Aparajita Mandal,
• Alapan Dutta,
• Rengasamy Sivakumar,
• Sanjeev Kumar Srivastava and
• Tapobrata Som

Beilstein J. Nanotechnol. 2024, 15, 350–359, doi:10.3762/bjnano.15.31

• inhibition of crystallization at lower thicknesses arises mainly because of a considerable contribution of the surface energy to the total Gibbs free energy of crystallization, resulting in a higher crystallization temperature and/or time [47][48]. It can be concluded that the annealing condition (i.e., 673

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• cancer cell growth, slowing their proliferation and disrupting mitotic regulation, leading to the stimulation of the tumor suppressor gene p53 and the inhibition or inactivation of various signaling pathways [31][32]. Its widespread adoption in medicine can be attributed to its strong therapeutic

Assessing phytotoxicity and tolerance levels of ZnO nanoparticles on Raphanus sativus: implications for widespread adoptions

• Pathirannahalage Sahan Samuditha,
• Nadeesh Madusanka Adassooriya and
• Nazeera Salim

Beilstein J. Nanotechnol. 2024, 15, 115–125, doi:10.3762/bjnano.15.11

• ]. High concentrations of Zn are implicated in the shifting of soil microbial communities and inhibition of microbial enzymes, thereby affecting soil fertility [1]. The excess levels of Zn, disrupting soil homeostasis, negatively affects plants and human health by inducing acute toxicity due to the

• coir without displaying chlorosis, necrosis, or strong growth inhibition, indicating its tolerance to elevated Zn levels [47]. Its resilience may have implications not only for the plant but also for the surrounding soil environment, microflora, and potentially human health. Metal-based engineered

• noteworthy internalization of Zn by R. sativus at 10,000 mg/L exceeded the healthy level of Zn by 340%. Despite this, R. sativus demonstrated survival at 1000 mg/L without signs of chlorosis, necrosis, or growth inhibition, suggesting its Zn-tolerant nature. This study emphasized the need for proactive

Berberine-loaded polylactic acid nanofiber scaffold as a drug delivery system: The relationship between chemical characteristics, drug-release behavior, and antibacterial efficiency

• Le Thi Le,
• Hue Thi Nguyen,
• Liem Thanh Nguyen,
• Huy Quang Tran and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2024, 15, 71–82, doi:10.3762/bjnano.15.7

• inhibition concentration for MRSA. The release of BBR from PLA nanofiber scaffolds was best fit with Ritger–Peppas models, suggesting that BBR release was mainly controlled by a diffusion mechanism. Additionally, the BBR NPs/PLA nanofiber scaffold did not exhibit cytotoxic activity against MA-104 monolayer

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• model of visceral leishmaniasis. Percentages of inhibition in the liver and spleen were 82.4 ± 3.8% and 77.6 ± 5.5%, respectively [75]. The results of the studies highlighted in this topic confirm the relevance of the use of nanostructured formulations for the delivery of bioactive compounds and uptake

Fluorescent bioinspired albumin/polydopamine nanoparticles and their interactions with Escherichia coli cells

• Eloïse Equy,
• Jordana Hirtzel,
• Sophie Hellé,
• Béatrice Heurtault,
• Eric Mathieu,
• Morgane Rabineau,
• Vincent Ball and
• Lydie Ploux

Beilstein J. Nanotechnol. 2023, 14, 1208–1224, doi:10.3762/bjnano.14.100

• progressive inhibition of the deposition of a PDA film on the wall of the reaction beaker, which was mentioned above and observed above a certain amount of BSA (Figure 3a). This allowed us to assume that BSA molecules below a critical amount cannot surround all DA molecules (some DA molecules thus form a thin

• of pristine and fluorescent BSA/PDA NPs. This effect, which is not elucidated so far, was also observed regarding the growth of S. aureus populations (Supporting Information File 1, Figure S9). Especially the absence of E. coli growth inhibition by RhBITC-BSA/PDA NPs allows us to envisage the use of

• -BSA/PDA NPs with a BSA/DA ratio of 10 was determined by calculating the bacterial growth inhibition from absorption measurements at 620 nm. Measurements were acquired with a Multiskan spectrophotometer (Fisher Scientific, Illkich, France). One colony of E. coli or S. aureus was transferred from the

Low temperature atomic layer deposition of cobalt using dicobalt hexacarbonyl-1-heptyne as precursor

• Mathias Franz,
• Mahnaz Safian Jouzdani,
• Lysann Kaßner,
• Marcus Daniel,
• Frank Stahr and
• Stefan E. Schulz

Beilstein J. Nanotechnol. 2023, 14, 951–963, doi:10.3762/bjnano.14.78

• growth trend of these CVD experiments at 150, 125, 100, and 90 °C. The films grow with linear rates. We assume a linear dependency of type d = r·(t − t0) with film thickness d, deposition rate r, deposition time t, and the inhibition time t0, that is, the time where no CVD-like growth may occur. At

• deposition mechanism has changed. The thickness trend shows that the deposition seems to be inhibited in the initial phase as t0 rises significantly above 0. The assumed linear relationship has been plotted in Figure 3 for each deposition temperature. The calculated inhibition times are 13.2 min for 100 °C

• and 35.8 min for 90 °C. The slopes of the linear dependency on the temperature are plotted in Figure 4. This plot also includes the calculated inhibition times according to the assumed linear fit. This simplified assumption shows that the inhibition time in CVD mode rises significantly at temperatures

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• , complement activation, complement-dependent cytotoxicity, or by inhibition of signal transduction [20][21]. Molecular cancer targets Cancer is a highly heterogeneous condition that arises from several mutations in transforming and tumor suppressor genes. High rates of metastasis, invasion, relapse, and drug

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

• Giuliana Muraca,
• María Esperanza Ruiz,
• Rocío C. Gambaro,
• Sebastián Scioli-Montoto,
• María Laura Sbaraglini,
• Gisel Padula,
• José Sebastián Cisneros,
• Cecilia Yamil Chain,
• Vera A. Álvarez,
• Cristián Huck-Iriart,
• Guillermo R. Castro,
• María Belén Piñero,
• Matias Ildebrando Marchetto,
• Catalina Alba Soto,
• Germán A. Islan and
• Alan Talevi

Beilstein J. Nanotechnol. 2023, 14, 804–818, doi:10.3762/bjnano.14.66

• (Figure 12B), and the corresponding EC50 were calculated. Benznidazole and NLC-BNZ presented inhibition of the intracellular growth of the parasites even at the lowest concentration, with no significant differences observed between the treatments. Benznidazole and NLC-BNZ EC50 values were 3.15 and 3.33 µM